FAST BioMedical Overview
- Year Founded
-
2006

- Status
-
Private
- Employees
-
2

- Latest Deal Type
-
2ndary - Private
- Investors
-
10
FAST BioMedical General Information
Description
Developer of clinical-stage medical technology designed to measure blood volume and kidney function in a clinically viable way. The company's technology uses a fluorescent compound to identify signs and symptoms of kidney infections faster than a traditional lab test, enabling physicians to detect acute kidney failure by measuring the presence through markers that are injected into a patient's bloodstream and fluoresce with the use of the device.
Contact Information
Website
www.fastbiomedical.comCorporate Office
- 9075 North Meridian Street
- Suite 200
- Indianapolis, IN 46260
- United States
Corporate Office
- 9075 North Meridian Street
- Suite 200
- Indianapolis, IN 46260
- United States
FAST BioMedical Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
15. Secondary Transaction - Private | 01-Jan-2022 | Completed | Clinical Trials - Phase 4 | |||
14. Later Stage VC (Series B) | Completed | Clinical Trials - Phase 4 | ||||
13. Later Stage VC (Series A2) | 09-Aug-2019 | Completed | Clinical Trials - Phase 4 | |||
12. Angel (individual) | 01-Mar-2017 | Completed | Clinical Trials - Phase 4 | |||
11. Later Stage VC (Series A2) | 01-Feb-2017 | Completed | Clinical Trials - Phase 4 | |||
10. Grant | 02-Jan-2017 | Completed | Clinical Trials - Phase 4 | |||
9. Later Stage VC (Series A) | 01-Jan-2017 | Completed | Clinical Trials - Phase 4 | |||
8. Later Stage VC | 01-Jan-2017 | Completed | Clinical Trials - Phase 4 | |||
7. Grant | 01-Jan-2017 | $1.1M | $8.27M | Completed | Clinical Trials - Phase 4 | |
6. Later Stage VC (Series A1) | 30-Aug-2016 | $1.53M | $8.27M | Completed | Clinical Trials - Phase 4 |
FAST BioMedical Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series A2 | ||||||||
Series A1 |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
FAST BioMedical Comparisons
Industry
Financing
Details
FAST BioMedical Competitors (5)
One of FAST BioMedical’s 5 competitors is MediBeacon, a Venture Capital-Backed company based in Saint Louis, MO.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
MediBeacon | Venture Capital-Backed | Saint Louis, MO | ||||
Daxor | Corporation | Oak Ridge, TN | ||||
Avvio Medical | Venture Capital-Backed | San Francisco, CA | ||||
Transonic | Private Debt Financed | Ithaca, NY | ||||
Millar | Private Debt Financed | Houston, TX |
FAST BioMedical Patents
FAST BioMedical Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
AU-2019353114-A1 | Method and apparatus for determining interstitial volume | Inactive | 05-Oct-2018 | ||
CA-3114930-A1 | Method and apparatus for determining interstitial volume | Inactive | 05-Oct-2018 | ||
US-20200174018-A1 | Method and apparatus for determining interstitial volume | Inactive | 05-Oct-2018 | ||
EP-3860460-A4 | Method and apparatus for determining interstitial volume | Inactive | 05-Oct-2018 | ||
EP-3860460-A1 | Method and apparatus for determining interstitial volume | Inactive | 05-Oct-2018 | G01N33/6893 |
FAST BioMedical Signals
FAST BioMedical Investors (10)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
316 Investments | Venture Capital | Minority | ||
Ellipsis Ventures | Venture Capital | Minority | ||
National Institute of Diabetes and Digestive and Kidney Diseases | Government | |||
U.S. Department of Health and Human Services | Government | |||
Ariel Savannah Angel Partners | Angel Group | Minority |
FAST BioMedical FAQs
-
When was FAST BioMedical founded?
FAST BioMedical was founded in 2006.
-
Where is FAST BioMedical headquartered?
FAST BioMedical is headquartered in Indianapolis, IN.
-
What is the size of FAST BioMedical?
FAST BioMedical has 2 total employees.
-
What industry is FAST BioMedical in?
FAST BioMedical’s primary industry is Diagnostic Equipment.
-
Is FAST BioMedical a private or public company?
FAST BioMedical is a Private company.
-
What is FAST BioMedical’s current revenue?
The current revenue for FAST BioMedical is
. -
How much funding has FAST BioMedical raised over time?
FAST BioMedical has raised $34.7M.
-
Who are FAST BioMedical’s investors?
316 Investments, Ellipsis Ventures, National Institute of Diabetes and Digestive and Kidney Diseases, U.S. Department of Health and Human Services, and Ariel Savannah Angel Partners are 5 of 10 investors who have invested in FAST BioMedical.
-
Who are FAST BioMedical’s competitors?
MediBeacon, Daxor, Avvio Medical, Transonic, and Millar are competitors of FAST BioMedical.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »